Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 12.20
-0.10 (-0.81%)
Jun 18, 2026, 2:56 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.11 billion as of June 18, 2026. Its market cap has decreased by -33.48% in one year.
Market Cap
7.11B
Enterprise Value
3.57B
Revenue
185.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.20
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.11B, a decrease of -68.99%. That is a compound annual growth rate of -33.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 7.11B | -20.46% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 9.12B |
| AP Biosciences | 8.60B |
| Locus Cell | 8.52B |
| Gongwin Biopharm Holdings | 8.31B |
| PharmaEngine | 8.12B |
| Adimmune | 7.36B |
| TaiGen Biopharmaceuticals Holdings | 6.18B |
| Savior Lifetec | 6.16B |